Publication | Closed Access

Forecasting invasive pneumococcal disease trends after the introduction of 13-valent pneumococcal conjugate vaccine in the United States, 2010–2020

VaccinologyVaccinationInfectious Disease EpidemiologyVaccine SafetyPreventive MedicineEmerging Infectious DiseasesMedicineVaccine SurveillanceVaccine EfficacyInfection ControlPublic HealthVaccine HesitancyUnited StatesVaccine ResearchEpidemiology